Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).

Anticancer research - 1 Feb 2012

Stoehlmacher-Williams Jan, Obermann Luise, Ehninger Gerhard, Goekkurt Eray

Abstract excerpt

AIM: Associations between polymorphisms of the epidermal growth factor receptor (EGFR) and overall survival in patients with advanced carcinoma of the head and neck (HNSCC) receiving cetuximab based palliative treatment, were evaluated. MATERIALS AND METHODS: HNSCC patients (n=48) received cetuximab +/- chemotherapy. Samples for DNA extraction and clinical data were collected prospectively. Genotyping of four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cetuximab

Share to Cisplatin

Share to Head and Neck Neoplasms

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Survival Rate

Source

Identifiers

PMID: 22287728

Genes

EGFR
EGF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).PMID 22287728Read ↗

High prevalence of EGFR R479K polymorphism in Head and Neck Cancer Patients of Indian origin and is associated with poor prognosisSemantic proximity Read ↗

High prevalence of EGFR R479K (rs2227983) polymorphism in Indian Head and Neck Cancer Patients: Association with Unfavourable Clinical OutcomeSemantic proximity Read ↗

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patientsSemantic proximity Read ↗

EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.Semantic proximity Read ↗

A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.Semantic proximity Read ↗

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with ChemoradiationSemantic proximity Read ↗

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.